WHO urges Ebola treatments, vaccines be tested only in trials amid Bundibugyo outbreak
The World Health Organization has recommended that experimental treatments and vaccines for the Bundibugyo virus be tested only in clinical trials. This guidance comes in response to an outbreak in the Democratic Republic of the Congo and Uganda. Currently, there are no approved vaccines or therapies specifically for this virus, but several candidates are being prioritized for testing.
- ▪The WHO is working with affected countries to assess the safety and effectiveness of Ebola treatments and vaccines.
- ▪There are currently no approved vaccines or therapies specifically for the Bundibugyo virus disease.
- ▪The WHO is collaborating with authorities in Congo and Uganda to implement clinical trials under strict ethical standards.
Opening excerpt (first ~120 words) tap to expand
WHO urges Ebola treatments, vaccines be tested only in trials amid Bundibugyo outbreakSign up now: Get ST's newsletters delivered to your inboxA logo of the World Health Organisation (WHO) at the headquarters in Geneva, Switzerland, April 29, 2026. REUTERS/Denis BalibousePublished May 29, 2026, 03:29 AMUpdated May 29, 2026, 03:29 AMMay 28 - The World Health Organization said on Thursday that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.The guidance comes amid an outbreak in the Democratic Republic of the Congo, with cases also reported in Uganda, prompting WHO to convene expert groups to evaluate potential countermeasures.There are currently…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Straits Times — World.